# Window of Opportunity in Preserving Laryngeal Function Trial

> **NCT07423078** · PHASE2 · RECRUITING · sponsor: **Matthew Spector** · enrollment: 87 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
- Locally Advanced Laryngeal Squamous Cell Carcinoma
- Hypopharyngeal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Toripalimab
- **DRUG:** Carboplatin
- **DRUG:** Cisplatin
- **DRUG:** Paclitaxel
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT07423078
- **Lead sponsor:** Matthew Spector
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-06
- **Primary completion:** 2029-04-30
- **Final completion:** 2031-04-30
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07423078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07423078, "Window of Opportunity in Preserving Laryngeal Function Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07423078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*